- Live market news
- Stocks
- NRSN
Neurosense Therapeutics Ltd
NRSNStockUSA
1.395USD−0.025 (−1.76%)Live · 5 Nov, 20:59 UTC
Key figures
- Previous close
- 1.42
- Open
- 1.50
- Day range
- 1.34 – 1.59
- 52-week range
- —
- Volume
- 51.3K
Latest news on NRSNranked by Oyticker for market impact
- 45Impact
NeuroSense Updates Nasdaq Listing Compliance Status
NeuroSense Therapeutics (NRSN) issued a compliance update regarding its Nasdaq listing. The announcement provides no detail on the nature, severity, or resolution timeline of any compliance issue.
NRSNBiotechnologyHealthcare - 35Impact
NRSN H1 2026 Business Update – Late-Stage Clinical Progress
NeuroSense Therapeutics released a mid-year 2026 business update detailing progress on disease-modifying therapeutic candidates. The announcement provides operational and clinical milestones relevant to pipeline advancement and cash runway.
NRSNBiotechnologyPharmaceuticals
In detailthe same figures as in Oyticker Charts
Performance
1D−1.8%
Ranges & volume
Day1.34 – 1.59
52 weeks—
- Open
- 1.50
- Prev. close
- 1.42
Volume 51.3Kavg —
Risk · 1 year
Not enough historyRisk needs at least a month of daily sessions.
Seasonality
Not enough historySeasonality needs several months of data.
SEC filings
All its filingsWhat NRSN filed
- 2 Nov 2026
- 26 Oct 2026
- 19 Oct 2026
- 13 Oct 2026
- 2 Oct 2026
- 25 Sept 2026
- 9 Sept 2026
- 27 Aug 2026
- 13 Aug 2026
- 6 Aug 2026
- 31 Jul 2026
- 31 Jul 2026
- 22 Jul 2026
- 29 Jun 2026
- 25 Jun 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.